main-logo

ICD-10 Code D07.61 | Carcinoma in situ of scrotum Symptoms, Diagnosis, Billing

Carcinoma in situ of the scrotum is a localized, non-invasive malignancy characterized by abnormal cell growth confined to the scrotal tissue. It is clinically significant as it may progress to invasive cancer if left untreated. Accurate coding with ICD-10 Code D07.61 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring appropriate management and resource allocation.

What is ICD-10 Code D07.61 for Carcinoma in situ of scrotum?

ICD-10 Code D07.61 specifically denotes carcinoma in situ of the scrotum, indicating the presence of abnormal cells that have not invaded surrounding tissues. This code is utilized in clinical documentation and billing when diagnosing patients with this condition, facilitating accurate treatment planning and reimbursement processes.

ICD-10 Code D07.61 – Clinical Definition and Explanation of Carcinoma in situ of scrotum

Carcinoma in situ of the scrotum arises from the epithelial cells and is often associated with risk factors such as chronic irritation or exposure to carcinogens. It requires prompt medical attention to prevent progression to invasive cancer. Early detection and intervention are crucial for favorable outcomes.

Key Clinical Features:

  • Presence of scrotal lesions or abnormal growths.
  • Possible associated symptoms such as itching or discomfort.
  • Higher incidence in individuals with a history of skin conditions or exposure to carcinogenic substances.
  • Diagnosis typically confirmed through biopsy.

ICD-10 Code D07.61 for Carcinoma in situ of scrotum – SOAP Notes & Clinical Use

ICD-10 Code D07.61 is integral in SOAP notes for documenting the patient's symptoms, assessment findings, and treatment plans. It aids in both acute and chronic care settings, ensuring comprehensive patient management and facilitating accurate billing.

What Does ICD-10 Code D07.61 for Carcinoma in situ of scrotum Mean in SOAP Notes?

In SOAP notes, ICD-10 Code D07.61 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of carcinoma in situ of the scrotum. This ensures continuity of care, supports billing processes, and meets EHR documentation standards.

Treatment Options for ICD-10 Code D07.61 – Carcinoma in situ of scrotum

Prompt treatment of carcinoma in situ of the scrotum is essential to prevent progression to invasive cancer. Surgical excision is the primary treatment modality.

Antibiotic Therapy:

    Supportive Care:

    • Regular follow-up appointments to monitor for recurrence.
    • Patient education on self-examination techniques.
    • Psychosocial support to address emotional impacts.

    Infection Control:

      How to Document Symptoms of Carcinoma in situ of scrotum (ICD-10 D07.61) in SOAP Notes

      Subjective:

      • Patient reports a scrotal lump that has been present for several weeks.
      • Complaints of mild itching in the affected area.
      • No history of trauma or recent infections.
      • Denies pain or discharge from the scrotum.

      Objective:

      • Physical examination reveals a firm, non-tender scrotal mass.
      • No signs of inflammation or infection noted.
      • Biopsy results indicate carcinoma in situ.
      • Vital signs within normal limits.
      card-topcard-bottom

      Secure, compliant, and built for trust

      HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

      Learn more
      hipaa-icon

      SOAP Note Guidelines for Diagnosing Carcinoma in situ of scrotum (ICD-10 Code D07.61)

      Assessment:

      • Diagnosis: Carcinoma in situ of scrotum, classified as non-invasive.
      • ICD-10 Code: D07.61.
      • Contributing factors may include chronic irritation.
      • No evidence of metastasis at this time.

      Plan:

      • Refer for surgical consultation for excision of the lesion.
      • Educate the patient on the importance of follow-up care.
      • Schedule follow-up appointment in 4-6 weeks post-surgery.
      • Monitor for any signs of recurrence during follow-up visits.

      Treatment & Plan Section for ICD-10 Code D07.61 – Carcinoma in situ of scrotum

      • Surgical excision is the primary treatment approach.
      • Regular follow-up to monitor for recurrence is essential.
      • Patient education on self-examination and awareness of symptoms.
      • Psychosocial support may be beneficial for emotional well-being.

      Using ICD-10 Code D07.61 for Carcinoma in situ of scrotum in Billing & SOAP Note Compliance

      • Ensure accurate documentation of symptoms and clinical findings.
      • Use the code in appropriate clinical settings for accurate billing.
      • Align treatment plans with clinical guidelines to support justified billing.
      • Document any relevant patient history that may impact treatment.

      ICD-10 Code D07.61 in Medical Billing and Insurance for Carcinoma in situ of scrotum

      ICD-10 Code D07.61 is crucial for accurate billing in hospital, ER, or outpatient settings, ensuring proper reimbursement for services rendered.

      Billing Notes:

      • Document all relevant patient history and clinical findings to support the diagnosis.
      • Use the code in conjunction with procedure codes for surgical interventions.
      • Ensure compliance with payer-specific guidelines for documentation.
      • Include any additional codes for comorbidities or complications.

      Common CPT Pairings:

      CPT CodeDescription
      11600Excision, malignant skin lesion, face, ears, scalp, neck; excised diameter excised 0.5 cm or less.
      11100Biopsy of skin, subcutaneous tissue, or mucous membrane.
      99213Established patient office visit, Level 3.

      Frequently Asked Questions

      Common Questions About Using ICD-10 Code D07.61 for Carcinoma in situ of scrotum

      What are the risk factors for carcinoma in situ of the scrotum?

      Risk factors include chronic irritation, exposure to carcinogenic substances, and a history of skin conditions. Regular skin examinations are recommended for individuals at higher risk.

      How is carcinoma in situ of the scrotum diagnosed?

      Diagnosis typically involves a physical examination followed by a biopsy of the scrotal lesion to confirm the presence of abnormal cells.

      What treatment options are available for carcinoma in situ of the scrotum?

      The primary treatment is surgical excision of the affected tissue. Follow-up care is essential to monitor for recurrence.

      Is carcinoma in situ of the scrotum contagious?

      No, carcinoma in situ is not contagious. It is a localized cancer that does not spread from person to person.

      diamond-bg
      diamond-bg

      Get started with your 20 free notes

      Sign up for free
      main-logo

      AI-aided Sudsy Shorthand for ink-free practices

      support@soapsuds.io
      hipaa-logo

      Clinical Notes

      SOAP notes

      DAP notes

      AI medical notes

      © Copyright SOAPsuds 2025. All rights reserved